JAMIE THOMAS: Open Payments
NPI 1801409966 · ROME, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,453 in 147 payments from 18 companies in 2025. Trend: 2023 $1,790 · 2024 $1,625 · 2025 $3,453
Food & beverage: $3,435Education: $18
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 39 | $867 |
| Madrigal Pharmaceuticals | 11 | $402 |
| ABBVIE INC. | 23 | $388 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $318 |
| Regeneron Healthcare Solutions, Inc. | 5 | $252 |
| Ipsen Biopharmaceuticals, Inc | 8 | $227 |
| Phathom Pharmaceuticals, Inc. | 8 | $215 |
| QOL Medical, LLC | 7 | $161 |
| Ardelyx, Inc. | 5 | $128 |
| Gilead Sciences, Inc. | 5 | $93 |
Products named: TREMFYA, REZDIFFRA, DUPIXENT, VOQUEZNA, ENTYVIO, Sucraid, IQIRVO, RINVOQ.
Industry payments across NY — which companies pay providers there.
